1. Home
  2. CCI vs ILMN Comparison

CCI vs ILMN Comparison

Compare CCI & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crown Castle Inc.

CCI

Crown Castle Inc.

HOLD

Current Price

$78.79

Market Cap

33.1B

Sector

Real Estate

ML Signal

HOLD

Logo Illumina Inc.

ILMN

Illumina Inc.

HOLD

Current Price

$185.67

Market Cap

26.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCI
ILMN
Founded
1994
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.1B
26.7B
IPO Year
1998
2000

Fundamental Metrics

Financial Performance
Metric
CCI
ILMN
Price
$78.79
$185.67
Analyst Decision
Buy
Hold
Analyst Count
16
17
Target Price
$104.69
$124.24
AVG Volume (30 Days)
4.2M
1.9M
Earning Date
04-22-2026
04-30-2026
Dividend Yield
4.95%
N/A
EPS Growth
111.25
170.87
EPS
0.34
0.87
Revenue
$4,264,000,000.00
$4,343,000,000.00
Revenue This Year
N/A
$6.47
Revenue Next Year
$1.72
$5.58
P/E Ratio
$232.88
$217.56
Revenue Growth
N/A
N/A
52 Week Low
$73.75
$88.00
52 Week High
$115.76
$196.66

Technical Indicators

Market Signals
Indicator
CCI
ILMN
Relative Strength Index (RSI) 42.27 57.35
Support Level $77.89 $116.54
Resistance Level $92.92 $196.66
Average True Range (ATR) 2.28 6.85
MACD 0.48 -0.96
Stochastic Oscillator 55.91 50.14

Price Performance

Historical Comparison
CCI
ILMN

About CCI Crown Castle Inc.

Crown Castle owns or manages roughly 40,000 wireless towers in the United States. It leases space on its towers to wireless service providers, which install equipment to support their wireless networks. The company has a very concentrated customer base, with about 90% of its revenue from the Big Three US mobile carriers: Verizon, T-Mobile, and AT&T. Crown Castle has plans to divest its fiber business, which is expected to be finalized in the first half of 2026. After that, it will be a stand-alone tower operator. Crown Castle operates as a real estate investment trust.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: